Molina Healthcare (MOH) Projected to Release Quarterly Earnings on Wednesday

Molina Healthcare (NYSE:MOH) will likely be issuing its Q2 2026 results after the market closes on Wednesday, July 22nd. Analysts expect Molina Healthcare to post earnings of $1.37 per share and revenue of $10.8320 billion for the quarter. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Parties can check the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Thursday, July 23, 2026 at 8:00 AM ET.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 earnings per share for the quarter, beating analysts’ consensus estimates of $1.57 by $0.78. The firm had revenue of $10.80 billion for the quarter, compared to analysts’ expectations of $10.91 billion. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The business’s quarterly revenue was down 3.1% on a year-over-year basis. During the same period in the previous year, the firm earned $6.08 EPS. On average, analysts expect Molina Healthcare to post $5 EPS for the current fiscal year and $9 EPS for the next fiscal year.

Molina Healthcare Trading Up 0.1%

Molina Healthcare stock opened at $225.66 on Monday. The firm has a 50 day moving average of $203.43 and a 200 day moving average of $175.58. The firm has a market capitalization of $11.76 billion, a price-to-earnings ratio of 66.76 and a beta of 0.74. Molina Healthcare has a 12-month low of $121.06 and a 12-month high of $244.89. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.97.

Wall Street Analyst Weigh In

MOH has been the topic of several analyst reports. Sanford C. Bernstein set a $286.00 price target on shares of Molina Healthcare in a report on Monday, July 13th. Mizuho set a $215.00 price objective on shares of Molina Healthcare in a research note on Monday, June 8th. Zacks Research upgraded shares of Molina Healthcare from a “strong sell” rating to a “hold” rating in a research report on Monday, April 20th. Morgan Stanley lifted their target price on shares of Molina Healthcare from $146.00 to $167.00 and gave the company an “equal weight” rating in a research note on Thursday, June 4th. Finally, Weiss Ratings raised shares of Molina Healthcare from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, June 25th. Three analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $207.06.

Insider Buying and Selling at Molina Healthcare

In other news, insider Jeff D. Barlow sold 17,811 shares of the business’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $186.12, for a total value of $3,314,983.32. Following the transaction, the insider owned 67,175 shares of the company’s stock, valued at approximately $12,502,611. The trade was a 20.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Maurice Hebert sold 600 shares of the firm’s stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $191.55, for a total transaction of $114,930.00. Following the transaction, the chief accounting officer directly owned 12,815 shares of the company’s stock, valued at $2,454,713.25. The trade was a 4.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.44% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Quarry LP purchased a new position in shares of Molina Healthcare during the fourth quarter valued at about $32,000. Triumph Capital Management lifted its position in shares of Molina Healthcare by 4,625.0% in the fourth quarter. Triumph Capital Management now owns 189 shares of the company’s stock worth $33,000 after buying an additional 185 shares in the last quarter. Brown Brothers Harriman & Co. lifted its position in shares of Molina Healthcare by 96.1% in the fourth quarter. Brown Brothers Harriman & Co. now owns 249 shares of the company’s stock worth $43,000 after buying an additional 122 shares in the last quarter. MUFG Securities EMEA plc bought a new position in Molina Healthcare during the second quarter valued at approximately $48,000. Finally, DV Equities LLC bought a new position in Molina Healthcare during the fourth quarter valued at approximately $76,000. Institutional investors own 98.50% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.